INTRODUCTION
============

Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) constitute a large gene family that is widely expressed across eukaryotic phyla ([@B19]). Although originally named for the high affinity binding of 25-hydroxycholesterol by OSBP ([@B26]), it is now apparent that OSBP and other family members bind a variety of lipids including cholesterol, phosphatidylinositol polyphosphates (PIPs), and phosphatidylserine ([@B13]; [@B15]; [@B3]; [@B17]). In vitro analysis of several mammalian OSBP/ORPs and yeast Osh proteins indicates their principle function is the transport and exchange of lipids at membrane contact sites (MCS) between organelles ([@B15]; [@B31]). The activity of OSBP/ORPs at MCS would modify the local lipid environment; however, the pervasiveness of organelle MCS and the size of the gene family suggest the potential to globally modify membrane composition ([@B16]).

Endosomes make numerous contacts with the endoplasmic reticulum (ER) that facilitate organelle maturation, multivesicular body formation, and lipid exchange ([@B24]; [@B20], [@B21]). During the maturation of endosomes, internalized LDL cholesterol esters are hydrolyzed and cholesterol is transported by NPC1 and NPC2 to the limiting membrane of late endosomes/lysosomes (LEL) ([@B28]). ORP1L ([@B32]), ORP5 ([@B5]), and ORP6 ([@B18]) have been implicated in the subsequent transport of cholesterol from the limiting membrane to the ER, a critical step in the utilization and storage of exogenous cholesterol and regulation of de novo cholesterol synthesis. ORP1L is found at contact sites between the ER and the endosomes that are involved in cholesterol transfer ([@B32]; [@B4]) as well as endosomal maturation ([@B23]; [@B27]). The *OSBPL1* gene encodes the full-length ORP1L that consists of three N-terminal ankyrin motifs that interact with Rab7 on the surface of LEL, a two phenylalanine in an acid tract (FFAT) motif that binds the ER-resident protein vesicle-associated membrane protein-associated protein (VAP) and a C-terminal OSBP-related domain (ORD) that binds cholesterol and PIPs ([Figure 1A](#F1){ref-type="fig"}) ([@B9], [@B10]). The protein also has an N-terminal pleckstrin homology (PH) domain that binds PIPs on LEL ([@B9]). Association of ORP1L with LEL and VAP-dependent interactions with the ER are required for LDL cholesterol transport from the LEL to ER ([@B32]) and in the reverse direction when LDL cholesterol is absent ([@B6]). Knockout of ORP1L expression in cultured cells caused cholesterol retention in the LEL and reduced cholesterol delivery to the ER, as measured by decreased acyl-CoA:cholesterol acyltransferase (ACAT) activity and derepression of sterol-regulated genes. The ORP1L ORD also binds and extracts PI(4)P ([@B32]) and other PIPs, but these lipids were not transported in an in vitro assay ([@B4]). Instead, PI(4,5)P~2~ and PI(3,5)P~2~ are allosteric regulators of ORP1 membrane targeting and cholesterol binding at donor membranes ([@B4]).

![CRISPR knockout of ORP1L and ORP1S expression in HeLa cells. (A) Domain organization of ORP1L and ORP1S proteins expressed by the *OSBPL1* gene. The position of two gRNAs was used to delete a 1757 base pair region between exons 19 and 20. (B) PCR analysis of genomic DNA from HeLa and ORP1-null cells using primers flanking the deletion site. (C) HeLa, ORP1L-null, and ORP1-null cell lysates were immunoblotted with an ORP1 polyclonal antibody. (D) Cholesterol ester synthesis was measured by \[^3^H\]oleate incorporation in cells cultured in FCS (16 h), LPDS (16 h), or FCS plus 25-hydroxycholesterol (6 μM for 2 h, 25OH). Results are mean and SD of five experiments (unpaired *t* test, \**p \<* 0.01 compared with HeLa cells).](mbc-31-793-g001){#F1}

Elucidating the role of ORP1L in cholesterol trafficking is complicated by the presence of ORP1S, which has a cytoplasmic/nuclear distribution and is implicated in cholesterol transport from the plasma membrane (PM) to the ER and lipid droplets ([@B8]), oxysterol-activation of LXR in the nucleus ([@B12]), and, more recently, cholesterol transport to the PM ([@B31]). To determine the function of ORP1S, we deleted a region of *OSBPL1* in HeLa cells that ablated expression of ORP1L and ORP1S. These ORP1-null cells displayed reduced PM cholesterol and cholesterol efflux and altered cholesterol homeostasis that was consistent with a role for ORP1S in cholesterol transfer from the LEL to the PM. This is the first evidence that full-length and truncated products of an *OSBP* gene are involved in opposing lipid transfer pathways, in this case, the delivery of cholesterol to the PM or ER.

RESULTS
=======

Cholesterol delivery to the PM requires ORP1S
---------------------------------------------

We previously characterized ORP1L cholesterol transport activity using cells with a CRISPR/Cas9 deletion that ablated ORP1L but not ORP1S expression ([@B32]). To determine the role of ORP1S in cholesterol transport and homeostasis, CRISPR/Cas9 methodology was used to create a deletion in exons 19 and 20 that knocked out both ORP1L and ORP1S expression in HeLa cells ([Figure 1A](#F1){ref-type="fig"}). The deletion in a clonal cell line (termed ORP1-null) was confirmed by PCR of genomic DNA using primers that flanked the site ([Figure 1B](#F1){ref-type="fig"}) and by immunoblotting of control and ORP1-null cell lysates using an ORP1 antibody ([Figure 1C](#F1){ref-type="fig"}). Cholesterol esterification by ACAT was measured to determine how ORP1S and ORP1L double knockout affected LDL-cholesterol transport to the ER ([Figure 1D](#F1){ref-type="fig"}). As previously reported, ORP1L-null cells had reduced cholesterol esterification by ACAT indicating a defect in LDL-cholesterol transport to the ER ([@B32]). However, cholesterol esterification in ORP1-null cells cultured in fetal calf serum (FCS), LPDS, or 25OH was similar to control HeLa cells ([Figure 1D](#F1){ref-type="fig"}). This lack of effect on ACAT activity was observed in three other HeLa cell-derived ORP1-null cell lines (Supplemental Figure S1, A--C).

The normalization of ER cholesterol esterification in ORP1-null cells relative to ORP1L-null cells indicated a likely role for ORP1S in cholesterol transport from LEL to the ER or other organelles. To elucidate this transport function, the distribution of cellular cholesterol was determined in ORP1-null cells. Only when ORP1-null cells were cultured with human LDL was there a significant increase in unesterified and total cholesterol mass when compared with control HeLa cells ([Figure 2A](#F2){ref-type="fig"}). Filipin staining revealed that both ORP1L- and ORP1-null cells cultured in LDL had increased fluorescent puncta indicative of cholesterol accumulation in the LEL ([Figure 2B](#F2){ref-type="fig"}). Compared with control and ORP1L-null cells, filipin fluorescence in ORP1-null cells was noticeably reduced outside the LEL compartment implying reduced PM cholesterol. This finding was confirmed by coexpression of the cholesterol biosensor mCherry-D4H- and PH-PLCD1-GFP, which detects PI(4,5)P~2~ in the PM. ORP1-null cells had reduced mCherry-D4H fluorescence at the PM and increased D4H-positive puncta compared with HeLa cells ([Figure 2C](#F2){ref-type="fig"}). The deficiency in PM cholesterol in ORP1-null cells was significant compared with both HeLa and ORP1L-null cells ([Figure 2D](#F2){ref-type="fig"}). To determine whether the cholesterol content of the exofacial leaflet of the PM in ORP-1-null cells was affected, intact cells were incubated with purified mCherry-D4 and GFP-wheat germ agglutinin. A significant reduction in mCherry-D4 fluorescence was detected on ORP1-null cells indicating that both leaflets of the PM are cholesterol deficient ([Figure 2, E and F](#F2){ref-type="fig"}). Also, reduced extraction of \[^3^H\]cholesterol from ORP1-null cells by cyclodextrin indicated that the PM is cholesterol deficient relative to HeLa and ORP1L-null cells ([Figure 2G](#F2){ref-type="fig"}). However, this difference was observed only when ORP1-null cells were cultured in human LDL and could represent reduced cholesterol efflux from an intracellular cholesterol pool.

![Cholesterol mass and localization in ORP1-null cells. (A) Total and unesterified cholesterol mass was measured in cells cultured in FCS, LPDS, or LPDS plus 50 µg/ml human LDL (mean and SD of four experiments; \**p \<* 0.05 compared with matched HeLa cell controls). (B) Filipin fluorescence was imaged in cells cultured in LPDS (-LDL) or LPDS plus LDL (50 µg/ml) for 16 h. (C) Live cell confocal imaging of HeLa and ORP1-null cells coexpressing Cherry-D4H and PH-PLCD1-GFP-PH for 24 h. (D) Quantification of Cherry-D4H fluorescence in the PM of HeLa, ORP1L-null, and ORP1S-null cells from C. Scatter plots (mean and SD) are shown for three experiments involving 65--100 cells (one-way analysis of variance \[ANOVA\] with Tukey's multiple comparison, \*\*\**p \<* 0.001, \*\*\*\**p \<* 0.0001). (E) Hela and ORP1-null cells were fixed and incubated with Alexa Fluor 488-WGA and recombinant GFP-D4H. Images were captured by confocal microscopy. (F) Quantitation of GFP-D4H fluorescence intensity per cell from the images in E. Results (mean and SD) are from analysis of 50--60 cells (unpaired *t* test, \*\*\**p \<* 0.001). (G) The percentage of extraction of \[^3^H\]cholesterol by 1 mM cyclodextrin from HeLa, ORP1-null, and ORP1L-null cells. Results are the mean SD for a representative experiment repeated two other times with similar results.](mbc-31-793-g002){#F2}

We next determined whether the PM cholesterol deficiency in ORP1-null cells could be rescued by expression of wild-type ORP1S and ligand binding mutants ([Figure 3, A--C](#F3){ref-type="fig"}). Compared to cells expressing empty vector (GFP), GFP-ORP1L expression caused a slight but significant increase in D4H fluorescence on the PM but internal puncta were unaffected ([Figure 3, A and B](#F3){ref-type="fig"}). In contrast, expression of ORP1S-GFP resulted in a significant increase in mCherry-D4H fluorescence on the PM and a reduction in internal fluorescent puncta ([Figure 3, A and B](#F3){ref-type="fig"}). Expression of ORP1S with a ΔELSK sterol-binding defective (SBD) mutation ([@B30]) did not restore PM cholesterol based on quantitation of mCherry-D4H fluorescence. However, ORP1S with a mutation in the conserved H~138~H~139~ motif (HH/AA) required for PIP binding and allosteric regulation ([@B4]) restored PM D4H fluorescence similar to wild type ([Figure 3, A and B](#F3){ref-type="fig"}). This contrasts with ORP1L cholesterol transfer activity at LEL-ER contacts, which requires both sterol and PIP binding activity ([@B32]; [@B4]). ORP2 is another ORD-only variant that transfers cholesterol to the PM from endosomal compartments in exchange for PI(4,5)P~2~ ([@B31]). ORP2 is expressed in HeLa cells ([@B11]) but this is not sufficient to maintain PM cholesterol transport in the absence of both ORP1L and ORP1S ([Figure 2D](#F2){ref-type="fig"}). However, transient overexpression of ORP2 in ORP1-null cells ([Figure 3, D and E](#F3){ref-type="fig"}) significantly increased mCherry-D4H on the PM relative to vector controls ([Figure 3F](#F3){ref-type="fig"}).

![Expression of ORP1S restored PM cholesterol in ORP1-null cells. (A, B) ORP1-null cells were transiently cotransfected with vector (GFP) or GFP-tagged ORP1S constructs and mCherry-D4H. Fixed cells were imaged by confocal microscopy (A) and the percentage of D4H fluorescence in the PM of cells was quantified as described in *Materials and Methods* (B) (bar, 20 μm). Scatter plots (mean and SD) show the results from three experiments involving 50--200 cells per group (one-way ANOVA with Tukey's multiple comparison; \**p \<* 0.05, \*\**p \<* 0.01, \*\*\**p \<* 0.0001). (C) Cells transiently expressing GFP vector (lane1), ORP1S-GFP (lane 2), ORP1S-GFP-HH/AA (lane 3), or ORP1S-GFP-SBD (lane 4) were harvested and immunoblotted with a GFP antibody. (D) Cells transiently expressing vector (GFP) or ORP2-GFP and mCherry-D4H were imaged and analyzed as described in A and B (bar, 20 μm). (E) Anti-GFP immunoblot of extracts from ORP1-null cells expressing GFP vector (lane 1) or ORP2-GFP (lane 2). (F) Quantitation of mCherry-D4H fluorescence in the PM. Scatter plots show the results (mean and SD) of analysis of 50--70 cells per group (unpaired *t* test; \*\**p \<* 0.01).](mbc-31-793-g003){#F3}

If ORP1S transfers cholesterol from the LEL to PM, the protein must transiently interact with these organelles during the binding and release of ligand. A magnified view of the PM of ORP1-null cells expressing ORP1S-GFP and mCherry-D4H indicated regions of colocalization ([Figure 4A](#F4){ref-type="fig"}). Similarly, Flag-tagged ORP1S ([Figure 4B](#F4){ref-type="fig"}) and ORP1S-GFP cultured in lipoprotein deficient medium ([Figure 4C](#F4){ref-type="fig"}) or with LDL ([Figure 4D](#F4){ref-type="fig"}) contained a small fraction of ORP1S that was associated with PM. ORP1S was also variably expressed in the nucleus ([Figure 3A](#F3){ref-type="fig"}) and unaffected by culturing in the presence or absence of LDL ([Figure 4, C and D](#F4){ref-type="fig"}). Since ORP1S lacks the canonical membrane-targeting motifs found in ORP1L, a region of the ORD must interact with the PM during cholesterol transfer.

![ORP1S partially localizes on the PM. (A) Colocalization of ORP1S-GFP and mCherry-D4H on the PM of an ORP1-null cell (bar, 5 μm). (B) ORP1-null cells expressing ORP1S-Flag were cultured in 10% FCS and immunostained with an anti-Flag monoclonal. (C, D) ORP1-null cells expressing ORP1S-GFP were cultured in delipidated medium without or with LDL (50 μg/ml) for 16 h (bar, 20 μm). All images are confocal sections (1 μm), and magnified regions are boxed.](mbc-31-793-g004){#F4}

Cholesterol homeostasis in ORP1-null cells
------------------------------------------

Cholesterol accumulated in the LEL of ORP1S-null cells due to defective transport to the PM by ORP1S and to the ER by ORP1L. Despite the retention of cholesterol in LEL, ORP1-null cells had normal ACAT activity ([Figure 1D](#F1){ref-type="fig"}). Similarly, cholesterol, lanosterol, and fatty acid synthesis (measured by \[^3^H\]acetate incorporation) in ORP1-null cells cultured in the absence or presence of LDL was similar to HeLa cell controls ([Figure 5, A--C](#F5){ref-type="fig"}). There was a slight reduction in cholesterol synthesis in ORP1-null cells cultured in LDL. Cholesterol and lanosterol synthesis were also unaffected in three other ORP1-null cell lines; however, \[^3^H\]acetate incorporation into fatty acids was slightly increased in ORP1-null4 cells (Supplemental Figure S1, D and E). The expression of sterol-regulated genes (*SREBP1*, *LDLR,* and *HMGCR*) in ORP1-null cells was suppressed in the presence of LDL but poorly activated relative to controls when the cells were cultured in LPDS ([Figure 5D](#F5){ref-type="fig"}). However, the defect in transcriptional activation in LDL-free medium had no impact on cholesterol synthesis in ORP1-null cells ([Figure 5A](#F5){ref-type="fig"}). These data suggest that in the absence of ORP1S and ORP1L, an alternate pathway can deliver cholesterol to the ER and reestablish feed-back regulation.

![Cholesterol regulation in ORP1-null cells. (A--C) \[^3^H\]acetate incorporation into cholesterol (A), lanosterol (B) and fatty acids (C) was measured in HeLa and ORP1-null cells cultured in FBS or LPDS. Results are the mean and SD of 3 experiments (\*\**p \<* 0.01). (D) qPCR analysis of *SREBP1*, *HMGCR*, and *LDLR* expression in cells cultured in FCS or LPDS. Results are expressed relative to HeLa cells cultured in FBS, and are the mean and SD of 4 experiments (unpaired *t* test, \**p \<* 0.05 compared with similarly treated HeLa cells).](mbc-31-793-g005){#F5}

ORP1L-null cells had a transient delay in the uptake of BODIPY-LDL that was attributed to defects in the endosomal compartment due to loss of ORP1L tethering to the ER ([@B32]). Using the same assay, ORP1-null cells had a 50--60% decrease in BODIPY-LDL uptake at all time points ([Figure 6, A and B](#F6){ref-type="fig"}). Immuno­staining in ORP1-null cells revealed a more dispersed distribution of LDLR compared with HeLa cells but cell surface localization was unaffected ([Figure 6C](#F6){ref-type="fig"}). The expression of the LDLR protein in ORP1-null cells cultured in FCS or LPDS was similar to HeLa cells ([Figure 6, D and E](#F6){ref-type="fig"}). When cells were treated with bafilomycin to block lysosomal degradation, LDLR expression in HeLa and ORP1L-null cells was significantly increased severalfold ([Figure 6, D and E](#F6){ref-type="fig"}). In contrast, LDLR expression in bafilomycin-treated ORP1-null cells was unaffected, suggesting reduced LDLR recycling and delivery of LDL to the lysosomes for degradation. Compared to control and ORP1L-null cells, LDLR in ORP1-null cells was dispersed in cytoplasmic endosomes that did not localize with LAMP1 (Supplemental Figure S2A). Treatment of HeLa and ORP1L-null cells with bafilomycin caused increased perinuclear accumulation of LDLR in LAMP1-positive LEL (Supplemental Figure S2B). However, LDLR and LAMP1 in bafilomycin-treated ORP1-null cells remained relatively dispersed in the cytoplasm. Collectively, these results show that ORP1S has an important role in LDLR recycling and cargo delivery to the LEL.

![Reduced LDL uptake in ORP1-null cells. (A, B) Spinning disk confocal images of HeLa and ORP1-null cells cultured with BODIPY-LDL. Uptake of BODIPY-LDL was quantified as fluorescence intensity per cell (bar, 20 µm). Scatter plots (mean and SD) are from three experiments (20--27 fields of cells in total, *\*\*p \<* 0.001). (C) Immunofluorescence of total and cell surface LDLR (0.8 μm confocal sections). (D) Immunoblot analysis of LDLR expression in cells cultured in DMEM with FCS, LPDS, or LPDS plus bafilomycin (100 nM for 6 h). (E) From immunoblots in D, LDLR expression was quantified relative to actin. Results are the mean and SD of four to five experiments (unpaired *t* test, *\*p \<* 0.05; *ns*, not significant).](mbc-31-793-g006){#F6}

To determine whether cholesterol delivered to the PM by ORP1S was a substrate for efflux, the expression and activity of ABCA1 was measured in control, ORP1L-null, and ORP1-null cells ([Figure 7](#F7){ref-type="fig"}). ABCA1 protein expression in all three cell lines was increased by the LXR agonists 22-hydroxycholesterol (22OH) and T0901317, with a slightly greater induction of ABCA1 expression in ORP1L-null cells under basal and 22OH-stimulated conditions ([Figure 7A](#F7){ref-type="fig"}). The increase in ABCA1 expression in ORP1L-null cells did not affect cholesterol efflux activity compared with control HeLa cells ([Figure 7, B and C](#F7){ref-type="fig"}). Despite normal induction of ABCA1 protein by 22OH and T0901317 in ORP1-null cells, cholesterol efflux to apoAI remained at the level of unstimulated cells. Thus, the reduction in PM cholesterol caused by ORP1S deficiency negatively impacts ABCA1 activity.

![Reduced ABCA1-mediated cholesterol efflux in ORP1-null cells. (A) Cells received no addition (NA, solvent control), 1.0 µM T0901317, and 10 nM RA or 1 μM 22OH and 10 nM RA for 16 h. Cell lysates were immunoblotted for ABCA1 and OSBP. (B) Expression of ABCA1 was quantified relative to OSBP load control. Results are the mean and SD of six experiments (unpaired *t* test, \**p \<* 0.05, \*\**p \<* 0.001 compared with similarly treated HeLa cells). (C) The percentage of efflux of \[^3^H\]cholesterol to apoAI was measured as described in *Materials and Methods*. Results are the mean and SD of five experiments (unpaired *t* test, \**p \<* 0.05, \*\**p \<* 0.005 compared with similarly treated HeLa cells).](mbc-31-793-g007){#F7}

DISCUSSION
==========

There are numerous examples of alternative splicing or promoter usage in *OSBP* genes that result in the expression of "long" ORPs that are targeted to organelle MCS and "short" ORD-only ORPs ([@B19]). *OSBPL1* encodes ORP1L, which localizes to LEL-ER contact sites and transfers cholesterol, and a cytosolic ORP1S variant that lacks the ankyrin, FFAT, and PH domains in the N-terminus of ORP1L ([@B10]; [@B32]). To understand the functional significance of this differential expression pattern, we used cells with a double knockout of *OSBPL1* to show that its two protein products are involved in opposing cholesterol transport pathways from the LEL to the PM (ORP1S) or ER (ORP1L).

A striking phenotype of ORP1-null cells was a reduction in PM cholesterol and accumulation in the endolysosomal system. D4H and D4 cholesterol sensors were used to quantify depletion of cholesterol in the cytoplasmic and exofacial leaflets of the PM in ORP1-null cells. As well, filipin staining and extraction of radiolabeled cholesterol with cyclodextrin revealed that the PM was cholesterol depleted. The shift in cholesterol distribution between the PM and the LEL in ORP1-null cells caused only minor changes in total cholesterol mass. However, two functional consequences of this redistribution of cholesterol in ORP1-null cells were identified. First, ORP1-null cells had a significant deficiency in ABCA1-dependent efflux to apoA1 in the medium despite normal levels of ABCA1 protein expression. ABCA1 efflux was normal in ORP1L-null cells consistent with the proposal that ORP1S maintains a pool of cholesterol at the PM that is accessible to the D4H probe and ABCA1. Second, cholesterol deficiency in the PM or excess cholesterol in the endolysosomal compartment also negatively affected LDLR activity. ORP1-nulls had reduced BODIPY-LDL uptake but normal expression and surface localization of the LDLR. However, internalized LDLR was localized to a dispersed endosomal compartment in ORP1-null cells and did not significantly accumulate in response to a lysosomal inhibitor, suggesting that endocytic recycling and LDL delivery to the lysosomes was partially compromised. Despite the apparent inhibition of LDL uptake, ORP1-null cells still accumulated cholesterol in LEL pointing to a primary role for ORP1S and ORP1L in cholesterol egress from that compartment.

Coupled with the abnormal cholesterol distribution and PM dysregulation in ORP1-null cells was a paradoxical normalization of ER cholesterol homeostasis. To explain this, a model is proposed wherein ORP1L and ORP1S work in opposing pathways that export LDL-cholesterol to the ER and PM, respectively ([Figure 8](#F8){ref-type="fig"}). In wild-type cells, ORP1L transfers cholesterol to the ER, where it is esterified by ACAT and negatively regulates SREBP processing and cholesterol synthesis ([@B32]), and ORP1S transfers cholesterol to the PM. In cells lacking ORP1L, cholesterol transfer from the LEL is reduced by 60--70% but ORP1S continues to transfer cholesterol to the PM. The unabated removal of cholesterol from the LEL by ORP1S could further deplete the ER of cholesterol in ORP1L-null cells by competition with other LEL-to-ER cholesterol transfer pathways. In cells lacking both ORP1 variants, a new homeostatic balance is established due to inhibition of PM cholesterol transport and expansion of the LEL cholesterol pool, resulting in enhanced delivery to the ER. There are two potential mechanisms to explain this phenotype. First, ORP1L-independent cholesterol transfer to the ER could be in competition with ORP1S cholesterol transfer to the PM. In the absence of ORP1S, this alternate pathway would have access to an expanded cholesterol pool and enhance sterol delivery to the ER. Second, abnormal LDL uptake and cycling of the LDLR in ORP1-null cells could result in delivery of LDL-cholesterol to other endosomal compartments with ER cholesterol transport activities. For instance, a distinct population of STARD3-positive late endosomes receives LDL-cholesterol prior to those that are ORP1L-positive ([@B27]). The cholesterol esterification phenotype of ORPL-null and ORP1-null cells differs from a recent report that showed a 20--40% reduction in cholesterol esterification in single and double knockout HeLa cells, respectively ([@B4]). This discrepancy could be related to the shorter exposure to LDL-containing medium prior to measure radioactive oleate incorporation into cholesterol ester. Importantly, we observed that knockout of ORP1S in previously characterized ORP1L-null cells ([@B32]) normalized their low cholesterol esterification activity (see ORP1-null4 cells, Supplemental Figure S1B).

![ORP1L and ORP1S have opposing cholesterol transfer activities at the LEL. The distribution of cholesterol and ER cholesterol regulatory responses are shown in wild-type, ORP1L-null, and double knockout ORP1-null cells. Broken arrows in ORP1L- and ORP1-null cells indicate alternative ORP1L-independent cholesterol transfer pathways. The relative distribution of cholesterol in the ER, LEL, and PM is indicated by the grayscale. ACAT activity and cholesterol synthesis (Chol Syn) is indicated relative to wild-type conditions.](mbc-31-793-g008){#F8}

Expression of GFP-ORP1S in ORP1-null cells was sufficient to restore a normal distribution of cholesterol between the PM and the LEL. As expected, an ORP1S sterol-binding mutant was ineffective in this regard. However, the wild-type activity of ORP1S-HH/AA was unexpected since the same mutation in ORP1L prevented LEL-to-ER cholesterol transfer activity in cells ([@B32]; [@B4]) and, in ORP1-ORD, inhibited sterol transfer in a liposomal assay ([@B4]). The ORP1 ORD binds to all PIP species in vitro but does not transfer them between liposomes. Rather, PI(4,5)P~2~ and PI(3,4)P~2~ were identified as allosteric activators of ORP1S that promote membrane targeting and sterol extraction from LEL ([@B4]). Although the LEL appears to be the donor membrane for ORP1S transfer, the ability of the ORP1S-HH/AA to restore activity suggests a PIP-independent mechanism for LEL-to-PM transfer. ORP1S-GFP, which lacks canonical membrane-targeting motifs, was detected in the cytoplasm and occasionally on the PM with mCherry-D4H but not on LEL in HeLa cells ([Figure 4A](#F4){ref-type="fig"}). Thus, ORP1S is not regulated by PIPs at MCS like its full-length counterpart ORP1L and could primarily recognize and transfer cholesterol to membranes based on their sterol content.

ORP2 is another ORD-only protein that binds and transfers cholesterol to the PM in exchange for PI(4,5)P~2~ ([@B31]). HeLa cells express ORP2 but overexpression was required to restore PM cholesterol in ORP1-null cells, indicating that ORP2 and ORP1S function in the same pathway but are regulated by different mechanisms. ORP2 interacts with ORP1L on LEL as part of a concerted pathway to deliver LDL-cholesterol to the PM in HeLa cells ([@B11]). In our ORP1-null HeLa cells, ORP2 might not be fully active with respect to PM cholesterol transport due to the absence of ORP1L. Thus, ORP2 and ORP1S deliver cholesterol to the PM but ORP2 may require the presence of ORP1L and PI(4,5)P~2~ for optimal activity.

MATERIALS AND METHODS
=====================

Cell culture
------------

HeLa cells were cultured in DMEM with 10% FCS at 37°C in a 5% CO~2~ atmosphere. CRISPR/Cas9 gene editing ([@B22]) in HeLa cells was used to introduce a deletion in *OSBPL1* using two guide RNAs (gRNAs) targeting exons 19 (TGTATTCA­GTTAGGCGCTGT) and 20 (GCTTCTCAGTGGGAACGGAC) that disrupted the expression of ORP1L and ORP1S ([Figure 1A](#F1){ref-type="fig"}). Immunoblotting indicated that these cells, referred to hereafter as ORP1-null (clone 16-5), had no detectable expression of ORP1L and ORP1S ([Figure 1C](#F1){ref-type="fig"}). Additional double knockout HeLa cell lines were generated as follows: ORP1-null2 cells (clone 89-S3) were derived by targeting HeLa cells with the exon 19 gRNA, ORP-null3 (clone 16-10) were isolated during screening for ORP1-null cells (see above), and ORP1-null4 cells (clone 81-3) were derived by targeting ORP1L-null cells ([@B32]) with exon 19 and 20 gRNAs. All ORP1-null cells were isolated by limiting dilution and verified by PCR (forward primer; TCCATGGTATTAGGTGCTC: reverse primer; TTCTCCTCTTCATCTGCAA­CGC), genomic sequencing, and immunoblotting for ORP1 isoforms. Cells were transiently transfected for 24 or 48 h with ORP1L and ORP1S expression vectors using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).

Analysis of cholesterol ester and cholesterol synthesis
-------------------------------------------------------

Cholesterol esterification was measured by incubating cells with 100 μM \[^3^H\]oleate/bovine serum albumin (BSA) (6:1 mol/mol) for 4 h ([@B7]), extraction of the oleate-labeled lipids from dishes with hexane:isopropanol (3:2, vol/vol), and separation by thin-layer chromatography in hexane:diethylether:acetic acid (90:30:1, vol/vol). Radioactivity in cholesterol esters and triglycerides was quantified by liquid scintillation counting and normalized to cell protein.

Sterol and fatty acid synthesis was measured by incubating HeLa cells with 2.5 μCi/ml \[^14^C\]acetate for 4 h ([@B2]). After extraction, lipids were saponified in ethanol and 50% (wt/vol) KOH for 1 h at 60°C, extracted with hexane, and cholesterol and lanosterol were resolved by thin-layer chromatography in petroleum ether/diethyl ether/acetic acid (60:40:1, vol/vol) and radioactivity was measured by liquid scintillation counting. \[^3^H\]fatty acids were extracted from the hydrolysate with hexane after acidifying with HCl (pH *\<* 3). Radioactivity was measured by liquid scintillation counting and normalized to cell protein.

Immunoblotting and immunofluorescence
-------------------------------------

Cells were lysed in SDS sample buffer (12.5% SDS, 30 mM Tris-HCl, 12.5% glycerol, and 0.01% bromophenol blue, pH 6.8), heated at 90°C for 5 min, separated by SDS--PAGE, and transferred to nitrocellulose. The following primary antibodies were used: ORP1L (1:2000, Abcam, ab131165), LAMP1 and LAMP2 (1:1000, Developmental Studies Hybridoma Bank, 1D4B and H4B4), LDLR (1:2000, rabbit polyclonal Ab3143 targeting the C-terminus) ([@B25]), or actin (1:10,000, Sigma AC15). Proteins were visualized with IRDye-800-- or -680--conjugated secondary antibodies using an Odyssey Imaging System and application software v3.0 (LI-COR Biosciences).

Cells cultured on glass coverslips were fixed in 4% (wt/vol) paraformaldehyde and permeabilized with 0.05% (wt/vol) Triton X-100 at 4°C. Cells were probed with LAMP1 or LDLR antibodies and appropriate secondary Alexa Fluor--conjugated antibodies (1:5000, ThermoFisher) in phosphate-buffered saline (PBS) containing 1% (wt/vol) BSA. Confocal imaging was performed using a Zeiss LSM510/Axiovert 200M microscope with a Plan-Apochromat 100×/1.40 NA oil immersion objective.

Cholesterol efflux to apoA1 and cyclodextrin
--------------------------------------------

ABCA1-mediated efflux was assayed as previously described ([@B1]). Cells were cultured on 12-well plates in DMEM containing 10% lipoprotein deficient serum (LPDS) and 10 µg/ml \[^3^H\]cholesterol (0.3 µCi/ml). At the same time, cells received the LXR activators T0901317 (1 µM) plus retinoic acid (10 nM) or 22OH (1 µM) plus retinoic acid (10 nM) to induce ABCA1 expression After 16--18 h, medium was removed and cells were incubated for 1 h in DMEM containing 5% LPDS and rinsed twice with 0.5 ml of warm serum-free DMEM. Cells were then incubated for 4 h in 0.5 ml of serum-free DMEM with or without 20 µg/ml human apoAI (controls received an equivalent amount of BSA). Medium was collected on ice and centrifuged at 10,000 × *g* for 1 min at 4°C to remove cellular debris, and radioactivity in the supernatant was quantified by liquid scintillation counting. Cells were rinsed in cold PBS and lysed in 0.5 N NaOH for 30 min, and radioactivity was measured by liquid scintillation. The percentage of cholesterol efflux to apoAI (minus BSA control) was calculated from dpm~medium~/ dpm~total~ (medium plus cell lysate)~\*~100.

For experiments involving cyclodextrin extraction, cells were cultured in 12-well plates in DMEM containing 50 mg/ml human LDL, 0.3 µCi/ml \[^3^H\]cholesterol for 24 h at 37°C. The medium was replaced with DMEM containing 5% FCS for 1 h, and cells were then rinsed twice with 0.5 ml of warm serum-free DMEM, followed by the addition of 0.5 ml of serum-free DMEM containing 1 mM of cyclodextrin. Over a period of 30 min, medium was collected on ice and subjected to centrifugation at 10,000 rpm for 1 min a 4°C to remove cellular debris, and the supernatant was collected and radioactivity was measured by liquid scintillation counting. Radioactivity in the cells was measured after lysis in 0.5 N NaOH for 30 min. The percentage of cholesterol extraction was calculated from dpm~medium~/dpm~total~ (medium plus cell lysate)~\*~100.

BODIPY-LDL uptake by cultured cells
-----------------------------------

Uptake of BODIPY-LDL (515~ex~/520~em~, ThermoFisher) by HeLa and ORP1L-null cells was quantified as described ([@B32]). Briefly, cells were cultured on 35-mm Cellview dishes (Greiner Bio-One) with DMEM containing 5% LPDS for 16 h and then incubated on ice for 15 min with DMEM containing BODIPY-LDL (10 μg/ml) (Molecular Probes, ThermoFisher). Dishes were then mounted on the 37°C environmentally controlled stage of a Zeiss Cell Observer spinning disk confocal microscope equipped with an Axiocam Hrm CCD and a 63× (1.4 NA) oil immersion objective. Fluorescence intensity was quantified in Z-stack images collected over 0.24-μm intervals.

Analysis of cellular cholesterol distribution and mass
------------------------------------------------------

Cellular cholesterol was visualized with filipin (0.25 µg/ml for 30 min) after cells were fixed in 4% paraformaldehyde. Total and unesterified cholesterol mass was measured using the Amplex Red method (ThermoFisher Scientific) and expressed relative to cell protein.

mCherry-D4H ([@B14]) and PH-PLCD1-GFP ([@B29]) were used to visualize cholesterol and PI(4,5)P~2~, respectively, after transient coexpression in HeLa and ORP1L-null cells for 24 h. Cells were mounted on an environmentally controlled stage of a Zeiss Cell Observer spinning disk confocal microscope at 37°C and imaged as described above. Cellular mCherry D4H fluorescence intensity was quantified from confocal images split into PLCD-PH (PM and cell outline) and mCherry-D4H channels using ImageJ (v1.46). The total area of the cell and the cytosol was chosen based on the PLCD-PH channel and added to the ROI manager list. In the mCherry-D4H channel, the fluorescence intensity of respective areas was measured based on the ROI manager list. The fluorescence intensity of the total cell area is designated as I~total~ while the cytosol is I~cytosol~. The mCherry-D4H fluorescence intensity on the PM is I~PM~ = (I~total~ -- I~cytosol~) and was expressed as I~PM~/I~cytosol\*~100. In cells transfected with ORP1-GFP or ORP-GFP and mCherry-D4H, the total cell area was selected based on the cytoplasmic GFP signal. A 0.1- to 0.3-μm perimeter corresponding to the PM was manually selected based on GFP fluorescence. Both areas were added to the ROI manager and then applied to the mCherry-D4H channel, and fluorescence intensity was quantified as described above.

The cholesterol content of the exofacial leaflet of the PM was quantified using recombinant mCherry-D4 expressed in *Escherichia coli* (provided by Barbara Karten, Dalhousie University). Cells cultured on glass coverslips were incubated in PBS containing mCherry-D4 (10 μg/ml) and Alexa Fluor 488-wheat germ agglutinin (WGA; 0.8 μg/ml) for 20 min on ice. Cells were washed twice with cold PBS and fixed in 3% PFA for 10 min. Cells were mounted and imaged by confocal microscopy, and the fluorescence intensity of the PM was quantified in individual cells that were WGA positive.

PCR analysis
------------

Total RNA was isolated from cells (RNA Easy, Qiagen) and 1 µg was reverse transcribed (QuantiTect Reverse Transcription Kit, Qiagen). Quantitative PCR (qPCR) was performed on a CFX96 Real-Time System (Bio-Rad) using the 2^-ΔCt^ method with normalization to *GAPDH*. The primer sets used to *SREBP1*, *LDLR*, *HMGCR*, and *GAPDH* were previously described ([@B32]). Reverse transcriptase-PCR analysis of *OSBPL1* mRNA expression was determined using primers flanking the deletion site.
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ACAT

:   acyl-CoA:cholesterol acyltransferase

BSA

:   bovine serum albumin

ER

:   endoplasmic reticulum

FCS

:   fetal calf serum

FFAT

:   two phenylalanine in an acid tract

gRNA

:   guide RNA

LEL

:   late endosomes/lysosome

LPDS

:   lipoprotein-deficient serum

MCS

:   membrane contact sites

22OH

:   22-hydroxycholesterol

ORD

:   OSBP-related domain

ORP

:   OSBP-related protein

OSBP

:   oxysterol binding protein

PBS

:   phosphate-buffered saline

PH

:   pleckstrin homology

PIP

:   phosphatidylinositol polyphosphates

PM

:   plasma membrane

SBD

:   sterol-binding defective

VAP

:   vesicle-associated membrane protein-associated protein

WGA

:   wheat germ agglutinin.
